Oct. 20, 2005 (Montreal) — A transdermal cream formulation of alprostadil may be an effective treatment for female sexual arousal disorder (FSAD), according to phase 2 research. Alprostadil is a ...

Retention and migration of a specially designed alprostadil transdermal cream was assessed after single-dose administration to the glans meatus of the penis. Seven men were enrolled in this two-way ...

May 25, 2012 (Atlanta, Georgia) — A new formulation of alprostadil cream 0.4% (Femprox, Apricus Biosciences Inc), administered topically, significantly improved symptoms of female sexual arousal ...

In 2 randomised controlled trials (RCTs) alprostadil 300 microgram cream statistically significantly improved erectile function and intercourse ability compared with placebo but the average absolute ...

Femprox (R) is a 0.4% alprostadil cream intended for the treatment of FSAD. To date, Apricus Bio has completed nine clinical studies with Femprox (R), including one, 98-patient Phase II study in the U ...

A Viagra-like cream is in the works to help women who have trouble getting aroused during sex. Now in the testing stages is Femprox, a topical cream which, when dabbed on the right places, may be the ...

Ferring Pharmaceuticals purchased ex-U.S. assets and rights to Apricus Biosciences’ on-demand topical erectile dysfunction therapy cream Vitaros ® (alprostadil) for potentially $12.7 million. Ferring ...

As partner Mylan NV makes ready to launch in Canada the erectile dysfunction (ED) drug-device combo Vitaros (alprostadil cream) – approved there as well as certain countries in Europe, Latin America ...

Overview: Alprostadil is used to diagnose and treat erectile dysfunction (ED). The most common side effect with alprostadil is penis pain. Serious side effects are rare but can include an unwanted ...